Johnson & Johnson explores $20 billion sale of orthopedics unit, source says

Johnson & Johnson is planning to sell its orthopedics unit, DePuy Synthes. The deal could be worth more than twenty billion dollars. Private equity firms are seen as the most probable buyers. This move follows J&J's earlier announcement to spin off the unit. The company is gathering financial documents for potential buyers. Rival medical device companies may also show interest.